Abstract
Canine Visceral leishmaniasis (CanL) poses a severe public health threat in several countries. Disease progression depends on the degree of immune response suppression. MicroRNAs (miRs) modulate mRNA translation into proteins and regulate various cellular functions and pathways associated with immune responses. MiR-21 and miR-148a can alter the parasite load and M1 macrophages are the principal cells in dogs’ leishmanicidal activity. A previous study found increased miR-21 and miR-148a in splenic leukocytes (SL) of dogs with CanL using microarray analysis and in silico analysis identified PTEN pathway targets. PTEN is involved in the immune regulation of macrophages. We measured PTEN and the production of reactive oxygen species (ROS) and nitric oxide (NO) before and after transfection SLs of dogs with CanL with mimic and inhibition of miR-21 and miR-148a. PTEN levels increased, NO and ROS decreased in SLs from dogs with CanL. Inhibition of miRNA-21 resulted in PTEN increase; in contrast, PTEN decreased after miR-148a inhibition. Nitrite (NO2) levels increased after transfection with miR-21 inhibitor but were decreased with miR-148a inhibitor. The increase in miR-21 promoted a reduction in ROS and NO levels, but miR-148a inhibition increased NO and reduced ROS. These findings suggest that miR-21 and miR-148a can participate in immune response in CanL, affecting PTEN, NO, and ROS levels.
1 Introduction
Visceral leishmaniasis occurs in several countries, and approximately 300,000 new cases are registered yearly. The countries with the highest recorded cases are Bangladesh, Brazil, Sudan, India, Ethiopia, and South Sudan (WHO, 2015). In Brazil, there are records of several species of Leishmania causing VL, including L. infantum and L. amazonensis in dogs (Tolezano et al., 2007; Sanches et al., 2016) and humans (; ).
Dogs are reservoirs of L. infantum and can develop skin lesions, splenomegaly, weight loss, onychogryphosis, diarrhea, and lymphadenopathy (Tonin et al., 2016). In Leishmania infection, the parasite proliferates in tissues such as the liver, spleen, and bone marrow lead to functional impairment of these tissues. The spleen is where L. infantum can be preserved. During infection, the parasite modifies the structure of the spleen and compromises its function to favor its survival, leading to immunomodulation and disease progression ().
In the spleen, granulomas can form with macrophage infiltration and rare plasma cells and lymphocytes (). In dogs with visceral leishmaniasis, the number of macrophages in the spleen is significantly elevated (Taffuri et al., 1996; ).
Immunosuppression favors parasite proliferation in several ways. The increased expression of the Th1 response with increased cytokines such as Interferon-γ (IFN-γ), Interleukin-2 (IL-2), and Tumor necrosis factor-α (TNF-α) might help to control the proliferation (). However, if the immune response is also directed toward the M2 macrophage profiles, there may be an anti-inflammatory response with increased Interleukin-10 (IL-10) (), which is not beneficial for humans and mice, leading to an increased susceptibility to disease (). The parasite can modulate the immune response through the action of miRNAs (miRs) and direct the immune profile to a Th2 response ().
MicroRNAs (MiRNAs) participate in several pathophysiologies and pathways in the immune system, they are essential for developing drugs that target mRNA (Wahid et al., 2014) and can decrease or increase expression of its target gene in transcriptional or post-transcriptional level (Zhang et a., 2014; Sadakierska-Chudy, 2020). A study with miR-10a reported that miR regulates ribosome biogenesis binding to 5′Untranslated Region (UTR) and increases Ribosomal Protein (RP) production in mice (). Epigenetic factors or pathologies can deregulate miRNA expressions and contribute to disease development (Sadakierska-Chudy, 2020).
In Canine Visceral leishmaniasis (CanL), the parasite regulates miRNA expression in splenic leukocytes (SLs) and increases miR-21 and miR-148a expression. In silico analysis showed that miR-21 and miR-148a affect several pathways, including PTEN (a tumor suppressor protein) and STAT3 (a signal transducer and transcription activator). The primary direct target genes are PTEN, SOS1, and FASLG, among others ().
MiR-21 can regulate PTEN in several diseases and it was studied in colorectal cancer (Wu et al., 2017), diabetic retinopathy (), and endometrial carcinoma (Zhao et al., 2017). PTEN participate in proliferation, differentiation or cell growth in different cell types (; ; Wu et al., 2021), and its expression can be modulated by miRs via interactions with PTEN mRNA in the 3′ UTR region ().
MiR-148a also regulates PTEN expression in macrophages infected by Schistosoma japonicum in mice (). In addition, overexpression of miR-148a increases reactive oxygen species (ROS) levels in macrophages through the PTEN/AKT pathway in mice (). However, no studies demonstrate this mechanism in CanL.
MiR-21 is involved in L. infantum escape mechanisms by inhibiting the Th1 response in dogs with CanL (). MiR-21 expression in SLs from dogs with CanL also regulates CD69 expression on B lymphocytes and IL-10 levels (). These findings suggest that L. infantum modulates the immune response via miR-21 expression as a survival mechanism (). In addition, the decreased parasitic load in SL following the use of the miR-148a inhibitor suggests a critical role for this miR in developing microbicidal activity in CanL, and miR148a regulates immune response as demonstrated by reducing inducible nitric oxide synthase (iNOS), TNF-α, IL-6, and IL-12 (Rebech et al., 2023).
The PTEN pathway is the target of miR-21 and miR-148a (). PTEN controls the differentiation and activation of several immune cells and acts downstream from T- and B-cell receptors, costimulatory molecules, cytokine receptors, integrins, and growth factor receptors (Taylor et al., 2019). PTEN expression is present in M1 macrophages that promote increased inflammatory immune responses (). Loss of PTEN activity in humans and mice is associated with cellular and humoral immune dysfunction, lymphoid hyperplasia, and autoimmunity (Taylor et al., 2019). Decreased PTEN levels and PTEN/phosphoinositide 3-kinase (PI3K)-related genetic defects are involved in the emergence of autoimmune diseases and inflammatory disorders associated with lymphoid and myeloid cells. PTEN is a PI3K antagonist that converts PI-(3,4,5) triphosphate (PIP3) to PI(4,5) (PIP2) and can control PI3P activity. PI3P is a member of the PI3K family, and its increase can lead to immunodeficiencies (Taylor et al., 2019).
The oxidative stress can play an important role in the catalytic activity of PTEN. PTEN activity is low during ROS production and it can lead to activation of the PI3K/Akt pathway (Zhang et al., 2020) and the Nrf2 transcription factor (Rojo et al., 2014) that regulates antioxidant defense, including SOD and GPx (). Furthermore, high levels of ROS decreases the export of PTEN from the nucleus and lead to the accumulation of PTEN as a form of protection for the cellular DNA structure (). iNOS expression is also involved with PTEN reduction in patients with melanoma. Nitric oxide produced from iNOS can activate the PI3K/Akt pathway and affect the catalytic activity of PTEN. The consequence of PTEN loss is a poor clinical condition in human patients affected with this tumor (). However, increased levels of ROS and NO are important to eliminate Leishmania playing a protective role (Raja et al., 2016).
Splenic aspirates from patients with active L. donovani infection showed less mRNA PTEN expression than those from treated patients (Sudarshan et al., 2016). PTEN is involved with the immune response in leishmaniasis. PTEN-deficient macrophages showed a reduced ability to kill L. major in response to IFN-γ treatment, possibly because the mutant cells exhibited decreased TNF secretion that correlated with reductions in inducible iNOS expression and production (). In CanL, the M1 phenotype is associated with NO, which is involved in the long-term protection of dogs against natural L. infantum infection and the clinical presentation of leishmaniasis (). NO production depends on the precursor molecule l-arginine () and is induced by iNOS () to perform microbicidal activity as demonstrated in human leishmaniasis (), mice (), and dogs (Vouldoukis et al., 1996). M1 macrophages also produce ROS, which participate in the innate immune response and can be produced during the oxidative explosion from Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Saha et al., 2019).
This study aimed to evaluate the regulation of PTEN, ROS and NO levels by miR-21 and miR-148a in SLs from dogs with CanL.
2 Material and methods
2.1 Ethics committee approval
The Ethics Committee on Experimental Animal Research (COBEA) and the Ethics Committee on Animal Use (CEUA) of UNESP–São Paulo State University Júlio de Mesquita Filho, Araçatuba Campus, School of Veterinary Medicine—FMVA—approved the study, according to process 00624–2018.
2.2 Animals
We selected 17 adult dogs with CanL naturally infected by L. infantum of both sexes and various breeds and weights. The animals were aged between 2 and 5 years. Dogs with CanL were from the Araçatuba Zoonoses Control Center in the state of São Paulo. Confirmation of seropositivity to L. infantum was performed using an immunochromatographic test (DPP) and an indirect enzyme-linked immunosorbent assay (ELISA) (Supplementary Table S1), according to . All dogs had at least three clinical signs of CanL, including onychogryphosis, lymphadenopathy, cachexia, and periocular dermatitis (diffuse skin or ear tip). The dogs used were classified in the moderate stage as proposed by Solano-Gallego et al. (2009) and were classified based on complete blood counts (Supplementary Tables S2 and S3) and biochemical examinations (Supplementary Table S4).
The control group consisted of 5 healthy dogs of both sexes and various breeds and weights. The animals were aged between 2 and 5 years. All dogs in this group had negative serology results according to indirect ELISA and DPP, as proposed by . They also had complete blood counts and serum biochemistries within normal values. The diagnosis of afflicted animals was confirmed using real-time PCR (qPCR) (Ranasinghe et al., 2008) for parasitic DNA amplification and PCR-RFLP for species typing, according to Sanches et al. (2016).
2.3 Blood and spleen samples
5 mL of blood were drawn by jugular vein puncture and placed in tubes with an anti-coagulant (BD Vacutainer®, Franklin Lakes, NJ, United States of America) for the complete blood count and DNA extraction. An additional 5 mL of blood was collected and stored in a tube without an anti-coagulant for biochemical analysis and serum for the DPP and ELISA tests.
For the collection of spleen samples from the group of dogs with CanL, barbiturate anesthesia (Thiopental, Cristália Itapira, SP, Brazil) was induced by intravenous introduction, followed by infusion of 19.1% potassium chloride, according to the rules and resolution of No. 1,374, of 2 December 2020, and chapter VIII, article 27 of the Federal Council of Veterinary Medicine (Brazil). Splenic samples were then collected. Samples from control group were removed by surgical excision () and processed immediately for analysis.
2.4 Obtaining SLs
Total splenic leukocytes (SLs) (1.6 × 10⁵) were obtained from 2 cm3 fragments, added to 10 mL of RPMI-1640 medium (Sigma®, United States), and supplemented with 10% heat-inactivated fetal bovine serum, 0.03% l-glutamine, 100 IU/mL penicillin, and 100 mg/mL streptomycin. After removing debris with a cell strainer (BD Falcon Cell strainer, San Diego, CA, United States), the cell suspensions were processed with 10 mL of red blood cell lysis buffer containing 7.46 g/L of ammonium chloride (NH4ClO3) at 4 °C for 8 min, centrifuged at 2500 rpm for 9 min, and washed three times with phosphate-buffered saline at pH 7.2. RPMI-1640 medium (Sigma®, United States) was then added.
2.5 ELISA and DPP
DPP was performed according to the manufacturer’s instructions to perform screening. The sera were analyzed using indirect ELISA from of L. infantum promastigotes (MHOM/BR00/MER02) as the antigen. This technique was performed as described by .
2.6 DNA extraction
DNA extraction from spleen samples from dogs was performed using the commercial DNAeasy® kit (Qiagen, Valencia, California, 91355, United States) according to the manufacturer’s recommendations. The extracted DNA was quantified using a 260/280 nm spectrophotometer (NanoDrop Technologies ND 1000 UV/VIS, United States). The degree of purity was evaluated, and samples were stored at –20°C.
2.7 Determining the species of leishmania
The determination of Leishmania species was performed using PCR-RFLP (Supplementary Figure S1) to confirm L. infantum infection as described by Sanches et al. (2016), L. infantum (IOC/L0575-MHOM/BR/2002/LPC- RPV). The molecular weight marker was 100 bp (Invitrogen, Carlsbad, California 92008, United States).
2.8 Transfection of miR-21 and miR-148a
MiR-21 and miR-148a expression was evaluated previously in SL, and there was an increase in the expression of miR-21 () and miR-148a (Rebech et al., 2023). SLs were cultured at 1.6 × 105 in 24-well plates for 48 h at 37 °C in 5% CO2. All-Stars Negative control siRNA (Scrambled) (SCR), miR-21 mimic (5 nM), miR-148a mimic (5 nM), miR-21 inhibitor (50 nM), miR-148a inhibitor (50 nM) (miScript miRNA mimic and inhibitor Qiagen, United States) were used. Transfected cells were cultured using 3 μL of Hiperfect (Qiagen, United States) in each well, following the manufacturer’s instructions. Transfection rates were evaluated using a final concentration with 50 nM of AllStars Hs Cell Death Control siRNA reagent (Qiagen, United States), a blend of highly potent siRNAs that target genes essential for cell survival. Knocking down these genes induces a high degree of cell death. Transfection rates were measured using flow cytometry and the 7-AAD Viability Staining Solution reagent (BioLegend, United States), according to the manufacturer’s instructions. The average transfection rate for both groups was 20% (Supplementary Table S5).
The transfected cells were cultured at 37°C and 0.5% CO2. At 48 h after transfection, the cells were stained for NO and ROS, and cell lysates were used for PTEN evaluation. Culture supernatants from SLs were collected, centrifuged at 2500 rpm, and stored at –80°C for nitrite (NO2) measurement.
2.9 Detection of NO and ROS in SLs from infected and control dogs
To quantify NO, cell suspensions were treated with DAF2DA (2 μM) (Sigma-Aldrich, D225, São Paulo, Brazil) and incubated for 1 h at 37°C and 5% CO2. After labeling, samples were stored at 4°C in the dark until analysis using a flow cytometer (BD Accuri™ C5 flow cytometer), and the data were analyzed using BD Accuri™ C6 software (version 1.0.264.21). Cells (1 × 105/mL) from various experimental groups were evaluated by fluorescence at 10,000 events. Cells without labeling were used as a negative control to delimit the negative populations. After excluding the debris, the cellular fluorescence of the triazole product (DAF-2T) was collected in the FL1 channel, and myeloid cells were gated separately. The mean values of FL1 were used for NO quantification.
To measure ROS levels, 10 µM H2DCFDA (Introgen-Leiden Molecular Probes) was added to cell suspensions and incubated for 1 h at 37°C and 5% CO2. Phorbol 12-myristate 13-acetate (PMA, 10 µM) was added 30 min before analysis for the positive ROS control. After labeling, the ROS analysis procedure was identical for NO.
2.10 NO2 determination
The Griess method determined NO2 concentrations in supernatant samples collected after 48 h of culture. For this procedure, we used 50 µL of the culture supernatants and 50 µL of Griess reagent (including 0.1% of NEED and sulfanilamide in 5% phosphoric acid) and maintained the mixture at room temperature for 5 min. Optical density was measured at 540 nm in 96-well plates (Spectra Count, Packard BioScience Company, Meriden, CT, United States of America). The results were compared with a standard NO2 concentration curve (0.3–200 µM).
2.11 Protein concentrations and PTEN analysis
Cell lysates were used to measure PTEN after the equalization of protein levels in samples. Protein concentrations were measured using the Pierce® BCA Protein Assay Kit (Thermo Fisher Scientific). PTEN analysis was performed using the Pathscan® Total PTEN Sandwich ELISA Kit (Cell Signaling Technology). PTEN is highly conserved in humans and dogs, showing 93.5% homology with Canis lupus familiaris (BLAST/XP_546673.2). We performed according to the manufacturer’s instructions. The optical density at 450 nm was obtained in a 96-well plate reader (Spectra Count, Packard BioScience Company, Meriden, CT, United States).
2.12 Statistical analysis
The data were classified as non-parametric using the Shapiro-Wilk normality test. ROS, NO, and PTEN levels were compared between the CanL and control groups using the Mann-Whitney test. PTEN, NO, ROS, and NO2 with mimic, inhibitor, and SCR treatments were compared using analysis of variance, the Friedman test, and Dunn’s multiple comparison test. The data were classified as parametric using the Shapiro-Wilk. Mean ROS levels from non-transfected cells were compared with stimulated PMA cells using the t-test. NO2 and NO levels of miR-148a mimic, inhibitor, and SCR treatments in CanL were compared using analysis of variance with Dunnett´s multiple comparison test. Differences were considered significant when p < 0.05. Statistical analyses and graphs were generated using Graph Pad Prism 6 (Graph Pad Software, Inc. CA. United States).
3 Results
3.1 NO, ROS and PTEN concentrations in SLs of dogs with CanL
NO production was lower in SLs from dogs with CanL than in the control group (Figure 1A) (p = 0.0063). ROS production was lower in SLs from dogs with CanL than in the control (Figure 1C) (p = 0.0246), and PMA (positive control) increased ROS production in the CanL group (Supplementary Table S6). We measured PTEN from whole cell lysates, and levels were higher in SLs from dogs with CanL than from control (Figure 1E) (p = 0.0270). The dogs from the control group were tested serologically negative for L. infantum. A representative histogram of basal NO and ROS production in SLs from dogs with CanL and a control are shown in Figures 1B–D, respectively. NO and ROS production can stablish leishmanicidal activity (; ), suggesting that activity is impaired in spleen from dogs with CanL.
FIGURE 1
3.2 Effect of miR-21 and miR-148a on PTEN concentration in SLs of dogs with CanL
After SL transfection with miR-21 mimic and inhibitor, and miR-148a mimic and inhibitor, no significant difference was observed in PTEN level in the control group, when compared with SCR treated cells (Figures 2A–C) (p > 0.05). The transfection with miR-21 inhibitor, there was more increased PTEN concentration in cell lysates of dogs with CanL then when SCR oligonucleotides used as a transfection control (Figure 2B) (p = 0.0302), in contrast, in SL transfected with miR-148a inhibitor, there was less PTEN than in samples from dogs with CanL, than when SCR oligonucleotides used as a transfection control (Figure 2D) (p = 0.070). Based on sequence homology with humans, we can infer that miR-148a binds the 3′UTR region of the PTEN transcript based on TargetScan analysis. We also performed mirDIP analysis, demonstrating target scores of miR-21 and miR-148a (Supplementary Table S7).
FIGURE 2
3.3 Effect of miR-21 and miR-148a on NO concentration in SLs of dogs with CanL
In this study, we observed that NO production was lower in SLs from dogs with CanL that in the control. Next, we evaluated the effect of miR-21 and miR-148a transfection of SLs with mimic and inhibitor from dogs with the control group and CanL on the regulation of NO production. Transfected SLs were cultured at 37 °C and 5% CO2 for 48 h, and NO production was evaluated using flow cytometry. We did not find significant differences in the control group following treatment with the miR-21 mimic and inhibitor and miR-148a mimic and inhibitor, when compared with SCR treated cells (Figures 3A–C) (p > 0.05). By contrast, SLs from dogs with CanL transfected with miR-21 mimic, there was less NO than when SCR oligonucleotides were used as a transfection control (p = 0.0469) (Figure 3B). However, in SLs transfected with the miR-148a inhibitor, there was more NO production in dogs with CanL than when SCR oligonucleotides were used as a transfection control (Figure 3D) (p = 0.0462). A representative overlay histogram displays the action of mimic inhibiting NO production by miR-21 (Figure 3E) and the increase of NO production by miR-148a inhibitor (Figure 3F) in SLs from dogs with CanL.
FIGURE 3
3.4 Effect of miR-21 and miR-148a on NO2 production in SLs of dogs with CanL
We evaluated the effect of transfection with miR-21 mimic and inhibitor and miR-148a mimic and inhibitor on NO2 production in SLs from dogs of the control group and CanL. Transfected SLs were cultured at 37 °C and 5% CO2 for 48 h, and production was measured using the Greiss method in culture supernatants. No significant difference was observed in the control group following treatment with the miR-21 mimic and inhibitor and miR-148a mimic and inhibitor in NO2 production, when compared with SCR treated cells (Figures 4A–C) (p > 0.05). After transfection with miR-21 inhibitor from SLs of dogs with CanL, there was a more significant NO2 concentration in culture supernatants, than with SCR oligonucleotides used as a transfection control (Figure 4B) (p = 0.0359). However, the transfection with miR-148a inhibitor in SL, there was less NO2 in culture supernatants in dogs with CanL than when SCR (Figure 4D) (p = 0.0069).
FIGURE 4
3.5 ROS concentration and the effect of miR-21 and miR-148a on the regulation of its production in SLs of dogs with CanL
In this study, we observed that ROS production was lower in SLs from dogs with CanL than in the control. Next, we evaluated the effect of miR-21 and miR-148a transfection on ROS production in SL from dogs with the control group and CanL with mimic and inhibitor. No difference was observed after transfection with miR-21 mimic and inhibitor, and miR-148a mimic and inhibitor in the control group, when compared with SCR treated cells (Figures 5A–C) (p > 0.005). However, the transfection with miR-21 mimic gave rise to a decrease in ROS production in dogs with CanL compared to SCR oligonucleotides used as a transfection control (Figure 5B) (*p = 0.0469). After transfection with miR-148a inhibitor in SLs, ROS production was reduced in dogs with CanL, when compared to SCR (Figure 5D) (p = 0.0468). A representative overlay histogram of the action of mimic on the inhibition of ROS production by miR-21 (Figure 5E) and the inhibition of ROS production by the miR-148a inhibitor (Figure 5F) was shown in SLs from dogs with CanL.
FIGURE 5
4 Discussion
SLs from dogs with CanL show increased miR-21 and miR-148 targeting PTEN (). PTEN has several regulatory roles in the immune system, including shifting the macrophage profile from M2 to M1 (Sahin et al., 2014; ). To clarify the regulatory role of miR-21 and miR-148a targeting PTEN in CanL, SLs from dogs with CanL were transfected with mimic and inhibitor of miR-21 and miR-148a, and we measured PTEN, NO, and ROS levels.
PTEN concentrations increased in lysates from SLs from dogs with CanL. In contrast, less PTEN mRNA was observed during the active stage of L. donovani infection in human splenic cells (Sudarshan et al., 2016). This difference can be related to mRNA detection instead of protein, as in our study.
High PTEN levels were associated with decreased NO and ROS production by SLs, suggesting a possible inhibition of inflammatory response in CanL. Higher numbers of M2 macrophages were observed in spleens in CanL (). M2 polarization of macrophages with decreased NO and ROS possibly favors parasite survival. These findings suggest that L. infantum modulates PTEN, NO, and ROS levels. Nevertheless, more studies are needed to clarify this mechanism.
In our study, NO concentration was lower in SLs in the CanL group, confirming a result previously observed in CanL (). NO production was associated with microbicidal activity in CanL (Vouldoukis et al., 1996), and its low production by macrophages could explain the high parasite replication observed in the spleens of the CanL group.
We observed low concentrations of ROS in SLs in CanL. Similarly, splenic macrophages from mice infected with L. donovani showed low production of ROS (). In peripheral blood mononuclear cells from humans with visceral leishmaniasis, the parasite decreased the expression of NADPH oxidase, preventing respiratory bursts (). The parasite expresses lipophosphoglycan, glycoinositol phospholipids, and ceramides that inhibit the Protein Kinase C activation pathway associated with ROS production (). In CanL, this low production of ROS might facilitate disease progression. Our findings suggest that L. infantum regulates host molecules to decrease microbicidal activity.
Low ROS and NO in SLs from dogs with CanL were associated with high PTEN levels in cell lysates. Upregulation of PTEN causes modulation of PI3K/AKT (Protein Kinase B) signaling to reduce ROS generation (Xu et al., 2011). The PI3K/AKT/PTEN pathway is involved in the defense mechanisms against L. amazonensis (), and PTEN negatively regulates the activity of PI3K/AKT signaling by converting PIP3 to PIP2, by which PTEN exerts its tumor-suppressive effect. Notably, the intracellular growth of the parasite was impaired during PI3K/Akt signaling inhibition and in macrophages with knocked-down Akt 1 expression. iNOS expression were decreased when PI3K/Akt pathway were high expressed in macrophages infected with L. amazonensis (). In addition, PTEN is also inactivated during the oxidative stress process by ROS () and NO production in humans (). Low PTEN can lead to the activation of Nrf2 (Taguchi et al., 2014) that is responsible to modulate the antioxidative pathway and favors infection by L. infantum (Vivarini and Lopes, 2020). Our findings suggest that L. infantum regulates PTEN in CanL. However, it is necessary to investigate the participation of the PI3K/AKT pathway in dogs with CanL.
PTEN negatively regulated the expression of pro-inflammatory cytokines such as TNF-α in an experimental model of adjuvant-induced arthritis (). PTEN was associated with the downregulation of inflammatory cytokines in humans (Yan et al., 2019). In dogs with CanL, TNF is markedly reduced with increased parasite load (). TNF-α enhances NO production in canine macrophages (). Therefore, probable PTEN may regulate cytokines; however, this finding must be confirmed in CanL.
Inhibition of miR-21 in SLs increased PTEN concentrations in cell lysate from SLs in CanL. When bone marrow-derived stem cells from dogs were transfected with the miRNA-21 inhibitor, PTEN was upregulated (Yang et al., 2019). Studies with human cancer showed that downregulation of miR-21 increased PTEN expression, inhibited PI3K/AKT activity, promoted apoptosis, and reduced proliferation (; ). In human cells, miR-21 modulated gene expression directly at the PTEN 3′-UTR (), this mechanism could occur in dogs with CanL. Molecular studies are necessary to test this hypothesis. We suggest that L. infantum has the potential to change immune response through miR-21, which has the PTEN pathway as a target.
We showed an increased PTEN by miR-21 inhibition in SLs occurred while nitrites increased. The miR-21 mimic reduced NO in our study, Leishmania parasites are killed by macrophages activated by NO-dependent mechanism (Vouldoukis et al., 1996). Interestingly in vitro study shows PTEN-deficient macrophages reduce their ability to kill L. major in response to IFN-γ treatment, possibly because the mutant cells exhibited decreased TNF secretion that correlated with reductions in inducible iNOS expression and NO production (). In our study, high PTEN associated with inhibited miR-21 induced high NO2, suggesting a role for PTEN and miR-21 in parasitic control in CanL.
We observed low ROS concentration in SLs in CanL after transfection with miR-21 mimic. In a L. donovani infection mice model, the spleens of miR-21 knockout mice expressed higher transcripts of M2 macrophages (Varikuti et al., 2021), which are responsible for producing low ROS, impairing a defense mechanism that controls the disease in mice (). Our findings suggest that ROS is regulated by miR-21. However, further studies are needed to clarify these mechanisms and understand how this phenomenon affects immune response in CanL.
In the present study, inhibition of miR-148a in SLs reduce PTEN. Inhibition of miR-21 increased PTEN concentration in cell lysates from SLs in CanL. The luciferase assay showed that PTEN is a target of miR-148a in mice, and bioinformatics analyses showed that miR-148a binds the 3’ UTR of the PTEN gene (). We performed bioinformatics analysis and observed that miR-21 could regulate the PTEN pathway, while miR-148a has PTEN as a direct target. These findings suggest that PTEN expression can be regulated by more than one miRNA in CanL.
We observed SLs transfected with the miR-148a inhibitor there was more significant NO production, in contrast miR-148a mimic also decrease iNOS in SL in CanL (Rebech et al., 2023), and similar study observed that overexpression of miR-148a in peripheral blood cells of rats was associated with low iNOS (Yin et al., 2021). NO production by macrophages participates in the elimination of L. infantum and can be involved in Th1-type immune responses (Reza et al., 2019). These findings suggest that miR-148a participates in NO regulation and that L. infantum could use miR-148a expression to favor its survival.
The miR-148a inhibitor decreased ROS concentrations in dogs with CanL. Interestingly, in mice bone marrow, the overexpression of miR-148a-3p in macrophages promoted excessive production of ROS and was responsible for the bactericidal activity of M1 macrophages through the PTEN/AKT pathway (). ROS production from macrophages during L. donovani infection is responsible for eliminating the parasite (). The PI 3-Kinase pathway promotes oxidative stress with ROS production and can involve PTEN (). L. infantum could use this pathway to decrease ROS levels in CanL as a survival mechanism. We suggest further studies to confirm this finding.
We conclude that miR-21 and miR-148a participate in the immune responses against L. infantum by targeting the PTEN pathway. The parasite L. infantum can regulate ROS and NO production through miR-21 and miR148a expression for its survival in the host. These findings may contribute to future therapies targeting these miRs for treating CanL.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.
Ethics statement
The animal study was reviewed and approved by The Ethics Committee on Experimental Animal Research (COBEA) and the Ethics Committee on Animal Use (CEUA) of UNESP–São Paulo State University Júlio de Mesquita Filho, Araçatuba Campus, School of Veterinary Medicine—FMVA—approved the study, according to process 00624–2018. Written informed consent was obtained from the owners for the participation of their animals in this study.
Author contributions
JF conceptualization, data curation, formal analysis, investigation, methodology, resources, software, validation, visualization, writing, review and editing text. JB methodology. GR methodology. SC methodology. MS methodology. MSo methodology. FE methodology. PS methodology. VL conceptualization, data curation, formal analysis, funding acquisition, investigation, methodology, project administration, resources, supervision, writing, review and editing.
Funding
This work was supported by São Paulo Research Foundation (FAPESP) (www.fapesp.br), grant 2018/17261-5 and 2021/07283-4; Nacional Council for Scientific and Technological Development (CNPq), process 302165/2018-5 and 140460/2018-7. This study was also partially financed by the Coordination for the Improvement of Higher Education Personnel (CAPES)—Finance Code 001 student supported: (JHF, JPB, GTR, SFC).
Acknowledgments
I am very grateful to all my collaborators for their contributions to this research and CAPES and FAPESP for their financial support.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fgene.2023.1106496/full#supplementary-material
References
1
AraújoT. F.CalargaA. P.ZorgiN. E.RangelO.LevyC. E.GiorgioS. (2020). Phenotype evaluation of human and canine isolates of Leishmania infantum. Comp. Immunol. Microbiol. Infect. Dis.73, 101551. 10.1016/j.cimid.2020.101551
2
AtaydeV. D.HassaniK.FilhoA. S. L.BorgesA. R.AdhikariA.MartelC.et al (2016). Leishmania exosomes and other virulence factors: Impact on innate immune response and macrophage functions. Cell. Immunol.309, 7–18. 10.1016/j.cellimm.2016.07.013
3
AzevedoM. C. S.FonsecaA. C.ColaviteP. M.MelchiadesJ. L.TabanezA. P.CodoA. C.et al (2021). Macrophage polarization and alveolar bone healing outcome: Despite a significant M2 polarizing effect, VIP and PACAP treatments present a minor impact in alveolar bone healing in homeostatic conditions. Front. Immunol.12, 782566. 10.3389/fimmu.2021.782566
4
BallW. B.KarS.MukherjeeM.ChandeA. G.MukhopadhyayaR.DasP. K. (2011). Uncoupling Protein 2 negatively regulates mitochondrial reactive oxygen species generation and induces phosphatase-mediated anti-inflammatory response in experimental visceral leishmaniasis. J. Immunol.187, 1322–1332. 10.4049/jimmunol.1004237
5
BragatoJ. P.RebechG. T.FreitasJ. H.SantosM. O.CostaS. F.EugênioF. R.et al (2022). miRNA-21 regulates CD69 and IL-10 expression in canine leishmaniasis. PloS One17, e0265192. 10.1371/journal.pone.0265192
6
BuxbaumL. U. (2013). Leishmania mexicana infection induces IgG to parasite surface Glycoinositol phospholipids that can induce IL-10 in mice and humans. PLOS Negl. Trop. Dis.7, e2224. 10.1371/journal.pntd.0002224
7
Calegari-SilvaT. C.VivariniA. C.MiquelineM.SantosG. R. R. M.TeixeiraK. L.SalibaA. M.et al (2015). The human parasite leishmania amazonensis downregulates iNOS expression via NF-кB p50/p50 homodimer: Role of the PI3K/Akt pathway. R. Soc. Open Sci.5, 9. 10.1098/rsob.150118
8
CavalcantiA. S.Ribeiro-AlvesM.PereiraL. O. R.MestreG. L.FerreiraA. B. R.MorgadoF. N.et al (2015). Parasite load induces progressive spleen architecture breakage and impairs cytokine mRNA expression in Leishmania infantum-naturally infected dogs. PloS One10, e0123009. 10.1371/journal.pone.0123009
9
ChangC. J.MulhollandD. J.ValamehrB.MosessianS.SellersW. R.WuH. (2008). PTEN nuclear localization is regulated by oxidative stress and mediates p53-Dependent tumor suppression. Mol. Cell. Biol.28, 3281–3289. 10.1128/MCB.00310-08
10
DarrahP. A.PatelD. T.LucaP. M.LindsayR. W. B.DaveyD. F.FlynnB. J.et al (2007). Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Leishmania major Nat. Med.13, 843–850. 10.1038/nm1592
11
DasA.KamranM.AliN. (2021). HO-3867 Induces ROS-Dependent stress response and apoptotic cell death in Leishmania donovani. Front. Cell. Infect. Microbiol.11, 774899. 10.3389/fcimb.2021.774899
12
DingZ.OgataD.RoszikJ.QinY.KimS. H.TetzlaffM. T.et al (2021). iNOS associates with poor survival in melanoma: a role for nitric oxide in the PI3K-AKT pathway stimulation and PTEN S-Nitrosylation. Front. Oncol.11, 631766. 10.3389/fonc.2021.631766
13
GiriB. R.ChengG. (2019). Host miR-148 regulates a macrophage-mediated immune response during Shistosoma japonicum infection. Int. J. Parasitol.49 (13-14), 993–997. 10.1016/j.ijpara.2019.08.002
14
GonçalvesM. D.BortoletiB. T. S.Tomiotto-PellissierF.Miranda-SaplaM. M.AssoliniJ. P.CarlotoA. C. M.et al (2018). Dehydroabietic acid isolated from Pinus elliottii exerts in vitro antileishmanial action by pro-oxidant effect, inducing ROS production in promastigote and downregulation Nrf2/ferritin expression in amastigote forms of Leishmania amazonensis. Fitoterapia128, 224–232. 10.1016/j.fitote.2018.05.027
15
GrisardE. C. G.SteindelM.ShawJ. J.IshikawaE. A. Y. I.Carvalho-PintoC. J.Eger-MangrichI.et al (2000). Characterization of Leishmania sp. Strains isolated from autochthonous cases of human cutaneous leishmaniasis in Santa Catarina State, southern Brazil. Acta Trop.4, 89–93. 10.1016/s0001-706x(99)00054-6
16
GuzikT. J.KorbutR.Adamek-GuzikT. (2003). Nitric oxide and superoxide in inflammation and immune regulation. J. Physiol. Pharmacol.54, 469–487.
17
HuangF.ZhaoJ. L.WangL.GaoC. C.LiangS. Q.AnD. J.et al (2017). Mir-148a-3p mediates notch signaling to promote the differentiation and M1 activation of macrophages. Front. Immunol.8, 1327. 10.3389/fimmu.2017.01327
18
JorensP. G.VermeireP. A.HermanA. G. (1993). L-arginine-dependent nitric oxide synthase: A new metabolic pathway in the lung and airways. Eur. Respir. J.6, 258–266. 10.1183/09031936.93.06020258
19
KirsteinA. S.KehrS.NebeM.HanschkowM.BarthL. A. G.LorenzJ.et al (2021). PTEN regulates adipose progenitor cell growth, differentiation, and replicative aging. J. Biol. Chem.297, 100968. 10.1016/j.jbc.2021.100968
20
KumarP.PaiK.PandeyH. P.SundarS. (2002). NADH-oxidase, NADPH-oxidase and myeloperoxidase activity of visceral leishmaniasis patients. J. Med. Microbiol.51, 832–836. 10.1099/0022-1317-51-10-832
21
KurodaS.NishioM.SasakiT.HorieY.KawaharaK.SasakiM.et al (2008). Effective clearance of intracellular leishmania major in vivo require Pten in macrophages. Eur. J. Immunol.38, 1331–1340. 10.1002/eji.200737302
22
KwakY. D.MaT.DiaoS.ZhangX.ChenY.HsuJ.et al (2010). NO signaling and S-nitrosylation regulate PTEN inhibition in neurodegeneration. Mol. Neurodegener.5, 49. 10.1186/1750-1326-5-49
23
LeslieN. R.BennetD.LindsayY. E.StewartH.GrayA.DownesC. P. (2003). Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J.22, 5501–5510. 10.1093/emboj/cdg513
24
LiX. F.ChenX.BaoJ.XuL.ZhangL.HuangC.et al (2019). PTEN negatively regulates the expression of pro-inflammatory cytokines and chemokines of fibroblast-like synoviocytes in adjuvant-induced arthritis. Artif. Cells Nanomed Biotechnol.47, 3687–3696. 10.1080/21691401.2019.1661849
25
LimaV. M. F.GonçalvesM. E.IkedaF. A.LuvizottoM. C. R.FeitosaM. M. (2003). Anti-leishmania antibodies in cerebrospinal from dogs with visceral leishmaniasis. Braz J. Med. Biol. Res.36, 485–489. 10.1590/S0100-879X2003000400010
26
LimaV. M. F.FattoriK. R.SouzaF.EugênioF. R.SantosP. S. P.RozzaD. B.et al (2012). Apoptosis in T lymphocytes from spleen tissue and peripheral blood of L. (L.) chagasi naturally infected dogs. Vet. Parasitol.184, 147–153. 10.1016/j.vetpar.2011.08.024
27
LiuH. Y.ZhangY. Y.ZhuB. L.FengF. Z.YanH.ZhangH. Y.et al (2019). miR-21 regulates the proliferation and apoptosis of ovarian cancer cells through PTEN/PI3K/AKT. Eur. Rev. Med. Pharmacol. Sci.23, 4149–4155. 10.26355/eurrev_201905_17917
28
LiuW.YuM.XieD.WangL.YeC.ZhuQ.et al (2020). Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN/AKT pathway. Stem Cell. Res. Ther.11, 259. 10.1186/s13287-020-01756-x
29
LuJ. M.ZhangZ. Z.MaX.FangS. F.QinX. H. (2020). Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy. Exp. Eye Res.190, 107886. 10.1016/j.exer.2019.107886
30
LyuJ.YuX.HeL.ChengT.ZhouJ.ChengC.et al (2015). The protein phosphatase activity of PTEN is essential for regulating neural stem cell differentiation. Mol. Brain.8, 26. 10.1186/s13041-015-0114-1
31
MaQ. (2013). Role of Nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol.53, 401–426. 10.1146/annurev-pharmtox-011112-140320
32
MartiniC. C.AndradeJ. T.AlmeidaS. K. M.SilvaK. L. O.EugênioF. R.SantosP. S. P.et al (2018). Cellular apoptosis and nitric oxide production in PBMC and spleen from dogs with visceral leishmaniasis. Comp. Immunol. Microbiol. Infect. Dis.57, 1–7. 10.1016/j.cimid.2018.01.003
33
MauëlJ.RansijinA.RouillerY. (1991). Killing of leishmania parasites in activated murine macrophages is based on an L-arginine-dependent process that produces nitrogen derivatives. J. Leukoc. Biol.49, 73–82. 10.1002/jlb.49.1.73
34
MeloL. M.BragatoJ. P.VenturinG. L.RebechG. T.CostaS. F.GarciaL. E.et al (2019). Induction of miR21 impairs the anti-leismania through inihibition of IL-12 in canine splenic leukocytes. Plos one14, e0226192. 10.1371/journal.pone.0226192
35
MengF.HensonR.Wehbe-JanekH.GhoshalK.JacobS.PatelT. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology133, 647–658. 10.1053/j.gastro.2007.05.022
36
ModabberiF.GhadimiS. N.ShahriariradR.NadimiE.Karbalay-doustS.RashidiS.et al (2021). Stereological analysis of liver, spleen and bone of leishmania infantum-experimentally infected hamsters. Exp. Parasitol.228, 108137. 10.1016/j.exppara.2021.108137
37
MoreiraP. R. R.FernandoF. S.MontassierH. J.AndréM. R.VasconcelosR. O. (2016). Polarized M2 macrophages in dogs with visceral leishmaniasis. Vet. Parasitol.226, 69–73. 10.1016/j.vetpar.2016.06.032
38
NovaisF. O.NguyenB. T.BeitingD. P.CarvalhoL. P.GlennieN. D.PassosS.et al (2014). Human classical monocytes control the intracellular stage of Leishmania braziliensis by Reactive oxygen species. J. Infect. Dis.209, 1288–1296. 10.1093/infdis/jiu013
39
OlekhnovitchR.BoussoP. (2015). Induction, propagation, and activity of host nitric oxide: Lessons from leishmania infection. Trends Parasitol.31, 653–664. 10.1016/j.pt.2015.08.001
40
ØromU. A.NielsenF. C.LundA. H. (2008). MicroRNA-10a binds the 5’UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell.30, 460–471. 10.1016/j.molcel.2008.05.001
41
PanaroM. A.BrandonisioO.SistoM.AcquafreddaA.LeograndeD.FumarolaL.et al (2001). Nitric oxide production by leishmania-infected macrophages and modulation by prostaglandin E2. Clin. Exp. Med.1, 137–143. 10.1007/s10238-001-8025-0
42
PanaroM. A.BrandonisioO.CaprariisD.CavalloP.CianciulliA.MitoloV.et al (2008). Canine leishmaniasis in southern Italy: A role for nitric oxide released from activated macrophages in asymptomatic infection?Parasit. Vectors1, 10. 10.1186/1756-3305-1-10
43
PinelliE.GebhardD.MommaasA. M.HoeijM. V.LangermansJ. A. M.RuitenbergE. J.et al (2000). Infection of a canine macrophage cell line with leishmania infantum: Determination of nitric oxide production and anti-leishmanial activity. Vet. Parasitol.92, 181–189. 10.1016/s0304-4017(00)00312-5
44
QingjuanL.XiaojuanF.WeiZ.ChaoW.PengpengK.HongboL.et al (2016). miR-148a-3p overexpression contributes to glomerular cell proliferation by targeting PTEN in lupus nephritis. Am. J. Physiol. Cell. Physiol.310, C470–C478. 10.1152/ajpcell.00129.2015
45
RajaM. R. C.SrinivasanS.SubramaniamS.RajendranN.SivasubramanianA.MahapatraS. K. (2016). Acetyl Shikonin induces IL-12, nitric oxide, ROS to kill intracellular parasite Leishmania donovani in infected hosts. RSC Adv.6, 61777–61783. 10.1039/c6ra11510a
46
RanasingheS.RogersM. E.HamiltonJ. G. C.BatesP. A.MaingonR. D. C. (2008). A real-time PCR assay to estimate Leishmania chagasi load in its natural sand fly vector Lutzomia longipalpis. Trans. R. Soc. Trop. Med. Hyg.102, 875–882. 10.1016/j.trstmh.2008.04.003
47
RebechG. T.BragatoJ. P.CostaS. F.FreitasJ. H.SantosM. O.SoaresM. F.et al (2023). Mir-148a regulation interferes in inflammatory cytokine and parasitic load in canine leishmaniasis. PLOS Negl. Trop. Dis.17, e0011039. 10.1371/journal.pntd.0011039
48
RezaS.HasanN. A.MaryamN. F.FahimehB.GhahremaniA.GholamRezaH.et al (2019). Cytokine profile and nitric oxide levels in macrophages exposed to Leishmania infantum FML. Exp. Parasitol.203, 1–7. 10.1016/j.exppara.2019.05.004
49
RojoA. I.RadaP.MendiolaM.Ortega-MolinaA.WojdylaK.Rogowska-WrzesinskaA.et al (2014). The PTEN/NRF2 axis promotes human carcinogenesis. Antioxid. Redox Signal.21, 2498–2514. 10.1089/ars.2014.5843
50
Sadakierska-ChudyA. (2020). MicroRNAs: Diverse mechanisms of action and their potential applications as cancer epi-therapeutics. Biomolecules10, 1285. 10.3390/biom10091285
51
SahaS.BasuM.GuinS.GuptaP.MitterstillerA. M.WeissG.et al (2019). Leishmania donovani exploits macrophage heme oxygenase-1 to neutralize oxidative burst and TLR signaling-dependent host defense. J. Immunol.202, 827–840. 10.4049/jimmunol.1800958
52
SahinE.HaubenwallnerS.KuttkeM.KollmanI.HalfmannA.DohnalA.et al (2014). Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses. J. Immunol.193, 1717–1727. 10.4049/jimmunol.1302167
53
SanchesL. V.MartiniC. C.NakamuraA. A.SantiagoM. E. B.LimaB. D.LimaV. M. F. (2016). Natural canine infection by Leishmania infatum and Leishmania amazonensis and their implications for disease control. Braz. J. Vet. Parasitol.25, 465–469. 10.1590/S1984-29612016071
54
Solano-GallegoL.KoutinasA.MiróG.CardosoL.PennisiM. G.FerrerL.et al (2009). Directions for the diagnosis, clinical staging, treatment and preventing of canine leishmaniosis. Vet. Parasitol.165, 1–18. 10.1016/j.vetpar.2009.05.022
55
SudarshanM.SinghT.SinghB.ChakaravartyJ.SundarS. (2016). Supression of host PTEN gene expression for Leishmania donovani survival in Indian Visceral leishmaniasis. Microbes Infect.18, 369–372. 10.1016/j.micinf.2015.12.008
56
TaffuriW. L.BarbosaA. J. A.MichalickM. S. M.GeranoO.França-SilvaJ. C.Franca-SilvaJ. C.et al (1996). Histopathology and immunocytochemical study of type 3 and type 4 complement receptors in the liver and spleen of dogs naturally and experimentally infected with Leishmania (leishmania) chagasi. Rev. Inst. Med. Trop.38, 81–89. 10.1590/s0036-46651996000200001
57
TaguchiK.HiranoI.ItohT.TanakaM.MiyajimaA.SuzukiA.et al (2014). Nrf2 enhances Cholangiocyte expansion in Pten-deficient livers. Moll. Cell. Biol.34, 900–913. 10.1128/MCB.01384-13
58
TaylorH.LaurenceA. D. J.UhligH. (2019). The role of PTEN in innate and adaptive immunity. Cold Spring Harb. Perspect. Med.9, a036996. 10.1101/cshperspect.a036996
59
TolezanoJ. E.UlianaS. R. B.TaniguchiH. H.AraújoM. F. L.BarbosaJ. A. R.BarbosaJ. E. R.et al (2007). The first records of Leishmania (Leishmania) amazonensis in dogs (Canis familiaris) diagnosed clinically as having canine visceral leishmaniasis from Araçatuba County, São Paulo State, Brazil. Vet. Parasitol.149 (3-4), 280–284. 10.1016/j.vetpar.2007.07.008
60
ToninA. A.CaladoA. M. C.BottariN. B.DalenogareD.ThoméG. R.DuarteT.et al (2016). Novel markers of inflammatory response and hepatic dysfunction in canine leishmaniasis. Comp. Immunol. Microbiol. Infect. Dis.44, 61–64. 10.1016/j.cimid.2015.09.004
61
VarikutiS.VermaC.HolcombE.JhaB. K.VianaA.MaryalaR.et al (2021). MicroRNA-21 deficiency promotes the early Th1 immune response and resistance toward visceral leishmaniasis. J. Immun.207, 1322–1332. 10.4049/jimmunol.2001099
62
VivariniA. C.LopesU. G. (2020). The potential role of Nrf2 signaling in Leishmania infection outcomes. Front. Cell. Infect. Microbiol.9, 453. 10.3389/fcimb.2019.00453
63
VouldoukisI.DrapierJ. C.NusslerA. K.TselentisY.SilvaO. A.GentiliniM.et al (1996). Canine visceral leishmaniasis: Successful chemotherapy induces macrophage antileishmanial activity via the L-arginine nitric oxide pathway. Antimicrob. Agents.Chemother.40, 253–256. 10.1128/AAC.40.1.253
64
WahidF.KhanT.KimY. Y. (2014). MicroRNA and diseases: Therapeutic potential as new generation of drugs. Biochimie104, 12–26. 10.1016/j.biochi.2014.05.004
65
World Health Organization (2015). Visceral leishmaniasis: Control strategies and epidemiological situation update in east africa. Ethiopia: World Health Organization. https://apps.who.int/iris/bitstream/handle/10665/190168/9789241509657_eng.pdf?sequence=1&isAllowed=y.
66
WuY.SongY.XiongY.WangX.XuKe.HanB.et al (2017). MicroRNA-21 (MiR-21) promotes cell growth and invasion by repressing tumor suppressor PTEN in colorectal cancer. Cell. Physiol. biochem.43, 945–958. 10.1159/000481648
67
WuS.CaoL.KeL.YanY.LuoH.HuX.et al (2021). Knockdown of CENPK inhibits cell growth and facilitates apoptosis via PTEN-PI3K-AKT signalling pathway in gastric cancer. J. Cell. Mol. Med.25, 8890–8903. 10.1111/jcmm.16850
68
XuJ.TianW.MaX.GuoJ.ShiQ.JinY.et al (2011). The molecular mechanism underlying morphine-induced Akt activation: Roles of protein phosphatases and reactive oxygen species. Cell. biochem. Biophys.61, 303–311. 10.1007/s12013-011-9213-5
69
YanH.JiangL.ZouH.ChenT.LiangH.TangL. (2019). PTEN suppresses the inflammation, viability, and motility of AP-AR42J cells by activating the Wnt/β-catenin pathway. RSC Adv.9, 5460–5469. 10.1039/c8ra08998a
70
YangC.LiuX.ZhaoK.ZhuY.HuB.ZhouY.et al (2019). miRNA-21 promotes osteogenesis via the PTEN/PI3K/Akt/HIF-1α pathway and enhances bone regeneration in critical size defects. Stem Cell. Res. Ther.10, 65. 10.1186/s13287-019-1168-2
71
YinQ.WangP.WuX. (2021). MicroRNA-148 alleviates cardiac dysfunction, immune disorders and myocardial apoptosis in myocardial ischemia-reperfusion (MI/R) injury by targeting pyruvate dehydrogenase kinase (PDK4). Bioengineered12, 5552–5565. 10.1080/21655979.2021.1965812
72
ZhangY.FanM.ZhangX.HuangF.WuK.ZhangJ.et al (2014). Cellular microRNAs up-regulate transcription via interaction with promoter TATA-box motifs. RNA12, 1878–1889. 10.1261/rna.045633.114
73
ZhangY.ParkJ.HanS. J.YangS. Y.YoonH. J.ParkI.et al (2020). Redox regulation of tumor suppressor PTEN in cell signaling. Redox Biol.34, 101553. 10.1016/j.redox.2020.101553
74
ZhaoW.GengP.LiY.WeiX.ChengJ. (2017). MicroRNA-21 promotes endometrial carcinoma proliferation and invasion by targeting PTEN. Int. J. Clin. Exp. Pathol.10, 11489–11495.
Summary
Keywords
microRNA, ROS, NO, pten, nitrite, Leishmania infantum, splenic leukocytes
Citation
De Freitas JH, Bragato JP, Rebech GT, Costa SF, Dos Santos MO, Soares MF, Eugênio FR, Dos Santos PSP and De Lima VMF (2023) MicroRNA-21 and microRNA-148a affects PTEN, NO and ROS in canine leishmaniasis. Front. Genet. 14:1106496. doi: 10.3389/fgene.2023.1106496
Received
23 November 2022
Accepted
24 March 2023
Published
13 April 2023
Volume
14 - 2023
Edited by
Sandra Marcia Muxel, University of São Paulo, Brazil
Reviewed by
Eduardo Milton Ramos Sanchez, University of São Paulo, Brazil
Aislan Carvalho Vivarini, Federal University of Rio de Janeiro, Brazil
Updates
Copyright
© 2023 De Freitas, Bragato, Rebech, Costa, Dos Santos, Soares, Eugênio, Dos Santos and De Lima.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Valéria Marçal Felix De Lima, valeria.lima@unesp.br
This article was submitted to RNA, a section of the journal Frontiers in Genetics
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.